Tandem Diabetes Care
(NASDAQ) TNDM
Tandem Diabetes Care Financials at a Glance
Market Cap
$1.04BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$1.03B
Net Income (TTM)
-$94.55M
EPS (TTM)
-$1.40
P/E Ratio
-10.82
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$15.16
Volume
1,871,094.807
Open
$15.17
Price
$15.16
Volume
1,871,094.807
Open
$15.17
Previous Close
$15.16
Daily Range
$14.89 - $15.45
52-Week Range
$9.98 - $29.65
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$15.16
Volume
1,871,094.807
Open
$15.17
Previous Close
$15.16
Daily Range
$14.89 - $15.45
52-Week Range
$9.98 - $29.65
Estimated Earnings Date
Aug 6, 2026
TNDM News
TNDM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tandem Diabetes Care
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
2,500
CEO
John F. Sheridan, MBA
Website
www.tandemdiabetes.comHeadquarters
San Diego, CA 92121, US
TNDM Financials
Key Financial Metrics (TTM)
Gross Margin
54.93%
Operating Margin
-7.88%
Net Income Margin
-9.20%
Return on Equity
-68.29%
Return on Capital
-13.03%
Return on Assets
-8.20%
Earnings Yield
-9.24%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.04BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
68.53M
Volume
1.87M
Avg. Volume
2.37M
Financials (TTM)
Gross Profit
$564.40M
Operating Income
-$81.01M
EBITDA
-$71.90M
Operating Cash Flow
$19.61M
Capital Expenditure
-$23.25M
Free Cash Flow
-$3.64M
Cash & ST Invst.
$570.26M
Total Debt
$734.74M
Tandem Diabetes Care Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$247.22M
+5.5%
Gross Profit
$136.79M
+15.5%
Gross Margin
55.33%
N/A
Market Cap
$1.04BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$392.04K
N/A
Employees
2,650
N/A
Net Income
-$20.39M
+84.4%
EBITDA
-$13.75M
+88.2%
Quarterly Fundamentals
Total Cash
$570.26M
+54.7%
Total Debt
$734.74M
+49.0%
Accounts Receivable
$140.67M
+11.1%
Inventory
$126.40M
-10.5%
Long Term Debt
$714.63M
+65.5%
Short Term Debt
$20.11M
-67.3%
Return on Assets
-8.20%
N/A
Return on Invested Capital
-8.95%
N/A
Free Cash Flow
$4.79M
+122.5%
Operating Cash Flow
$11.05M
+160.5%